{
    "organizations": [],
    "uuid": "ce33284217e6c38afeb55dfdbff293f71953433a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-endo-expects-2018-us-generic-pharm/brief-endo-expects-2018-u-s-generic-pharmaceuticals-revenue-to-decline-in-the-mid-to-high-30-pct-range-versus-prior-year-idUSFWN1QH0VA",
    "ord_in_thread": 0,
    "title": "BRIEF-Endo Expects 2018 U.S. Generic Pharmaceuticals Revenue To Decline In The Mid-To High 30 Pct Range Versus Prior Year",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News February 27, 2018 / 2:59 PM / Updated 16 minutes ago BRIEF-Endo Expects 2018 U.S. Generic Pharmaceuticals Revenue To Decline In The Mid-To High 30 Pct Range Versus Prior Year Reuters Staff 1 Min Read Feb 27 (Reuters) - Endo International Plc: * ENDO CFO SAYS ,“WE EXPECT 2018 U.S. GENERIC PHARMACEUTICALS REVENUE TO DECLINE IN THE MID- TO HIGH 30% RANGE VERSUS PRIOR YEAR” - CONF CALL * ENDO CFO SAYS ,“U.S. BRANDED SPECIALTY AND ESTABLISHED PHARMACEUTICALS REVENUE IS EXPECTED TO DECLINE IN THE LOW TEENS VERSUS PRIOR YEAR” - CONF CALL * ENDO CFO SAYS U.S. BRANDED STERILE INJECTABLES REVENUE IS EXPECTED TO GROW IN THE LOW DOUBLE-DIGIT PERCENTAGE RANGE VERSUS PRIOR YEAR - CONF CALL * ENDO CFO SAYS INTERNATIONAL SEGMENT REVENUE IS EXPECTED TO DECLINE IN THE HIGH 40S PERCENTAGE RANGE - CONF CALL Further company coverage:",
    "published": "2018-02-27T16:58:00.000+02:00",
    "crawled": "2018-02-27T17:26:24.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "expects",
        "generic",
        "pharmaceutical",
        "revenue",
        "decline",
        "high",
        "pct",
        "range",
        "versus",
        "prior",
        "year",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "endo",
        "international",
        "plc",
        "endo",
        "cfo",
        "say",
        "expect",
        "generic",
        "pharmaceutical",
        "revenue",
        "decline",
        "high",
        "range",
        "versus",
        "prior",
        "year",
        "conf",
        "call",
        "endo",
        "cfo",
        "say",
        "branded",
        "specialty",
        "established",
        "pharmaceutical",
        "revenue",
        "expected",
        "decline",
        "low",
        "teen",
        "versus",
        "prior",
        "year",
        "conf",
        "call",
        "endo",
        "cfo",
        "say",
        "branded",
        "sterile",
        "injectables",
        "revenue",
        "expected",
        "grow",
        "low",
        "percentage",
        "range",
        "versus",
        "prior",
        "year",
        "conf",
        "call",
        "endo",
        "cfo",
        "say",
        "international",
        "segment",
        "revenue",
        "expected",
        "decline",
        "high",
        "40",
        "percentage",
        "range",
        "conf",
        "call",
        "company",
        "coverage"
    ]
}